Abbott to Acquire Action Pharma’s Investigational Compound, AP214

Abbott (NYSE: ABT) and Action Pharma A/S, a privately owned company, announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma. AP214 is in development t…
Read the full story: Breaking World Pharma News